Effect of turmeric on myoclonic seizure

Phase 2

• Conditions: Myoclonic seizure.; Myoclonic epilepsy

• Registration Number: IRCT2014121020266N1
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 33

Inclusion Criteria

children from 3 month to 14 years old; children with myoclonic seizure and spasm; children with rear seizure.
Exclusion criteria: children with underlying diseases(cardiac, renal, hepatic,...); children with growth malformation.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
umbet of seizure in 24 h. Timepoint: Daily. Method of measurement: Parents' report.

Secondary Outcome Measures

Name	Time	Method
iver, renal and hematologic side effects. Timepoint: Before and after curcumin and placebo advising. Method of measurement: Blood sampeling.